Select a country
-
Albania -
Andorra -
Austria -
Belarus -
Belgium -
Bosnia and
Herzegovina -
Bulgaria -
Croatia -
Czech Republic -
Denmark -
Estonia -
Finland -
France -
Germany -
Greece -
Holy See -
Hungary -
Iceland -
Ireland -
Italy -
Latvia -
Liechtenstein -
Lithuania -
Luxembourg -
Malta -
Moldova -
Monaco -
Montenegro -
Netherlands -
North Macedonia -
Norway -
Poland -
Portugal -
Romania -
Russia -
San Marino -
Serbia -
Slovakia -
Slovenia -
Spain -
Sweden -
Switzerland -
Turkey -
Ukraine -
United Kingdom - Other European Countries
lmraldiTM low-volume, citrate-free1
Enhancing your patients’ experience
lmraldiTM (adalimumab) low-volume, citrate-free1
Find out what has changed in the new ImraldiTM (adalimumab) formulation from the original ImraldiTM (adalimumab) and how this can benefit your patients.
LOW VOLUME
CITRATE-FREE
- A low injection volume2
- Citrate-free formulation
- Most patients prefer the ImraldiTM (adalimumab) pen over the Humira® (adalimumab) and Enbrel (etanercept) MyClic® pens due to reasons such as ease of use, ease of grip, and its button-free initiation mechanism3a
As indicated in a European patient / nurse survey.3a
lmraldiTM (adalimumab) indications
ImraldiTM (adalimumab) is indicated for a wide range of immune-mediated inflammatory diseases (rheumatological, dermatological and gastroenterological diseases).
Ophthalmological
diseases
Dermatological
diseases
Gastroenterological
diseases
Rheumatological
diseases
How to use lmraldiTM (adalimumab) pen and syringe
Key safety information to help with ImraldiTM (adalimumab) use in clinical practice.
ImraldiTM pre-filled pen
31 days out of the fridge stability1,a,b – up to a maximum of 25˚C (room temperature)
Audible Double Click3 – clicks signal the start and end of injection
Non-slip Surface3 – a tacky feel to help improve grip and control
Sure-grip Shape3 – four sided design to prevent the pen from rolling off surfaces with rounded corners for comfort and stability
Thin Needle2 – 29 gauge needle for comfort4
Latex Free2 – important for those patients with latex allergies
Medication Window1 – makes it easy to inspect the medicine and see the yellow indicator after injection is complete
Button Free3 – for patients with reduced manual dexterity
ImraldiTM pre-filled syringe
31 days out of the fridge stability1,a,b – up to a maximum of 25˚C (room temperature)
Stainless Steel4 – 29 gauge needle for comfort4
Wide Flange2 – tacky surface and expanded width for control and stability
Automatic Retracting Needle1 – after injection, automatically retracts for increased safety
Latex Free2 – important for those patients with latex allergies
a The syringe or pen must be protected from light, and discarded if not used within the 31-day period.
b The 31 days out of the fridge stability refers to Imraldi™ low volume citrate-free formulation.